|
 
|
 
D323
- Canine Leishmaniosis
Description:
Various species of
the genus Leishmania are the causative agents of visceral,
cutaneous, and mucocutaneous leishmaniosis in humans
and of leishmaniosis in dogs. With increasing international
travel, cases of imported leishmaniosis are regularly
diagnosed in dogs in areas where the disease is not
endemic. In dogs, Leishmania infantum is main causative
agent of canine leishmaniosis and usually causes chronic
systematic disease. Not every dog experimentally or
naturally infected with Leishmania develops disease.
Studies indicate that protective immunity to leishmaniosis
in dogs is mediated by T cells and the cytokines they
produce. The incubation period varies from 3 months
to as long as 7 years. Signs are highly variable and
often begin with slight but progressive dullness and
insidious exercise intolerance. Weight loss and muscle
atrophy are the most common signs canine leishmaniosis.
Some dogs lose weight despite having a ravenous appetite,
but serious loss of conditions is usually associated with anorexia and other signs of renal failure including
mental depression, polyuria, polydipsia, and vomiting.
Transient diarrhea may occur. Combined infection with
Erlichia, Babesia, and Dirofilaria are quite common
if Leishmania infection occurs in regions where these
organisms are also endemic.
Diagnosis:
For diagnosis of leishmaniosis
in dogs, serological methods, such as the indirect fluorescent-antibody
test, ELISA, and Western blotting, or in vitro cultivation
is of great value. However, diagnostic in vitro cultivation
is cumbersome (because it includes preparation of complex
media and time-consuming preparation of blood-containing
samples) and expensive. Cultivation for diagnostic purposes
takes in general 3 to 4 days and in few cases up to
10 days until positive results are obtained. In areas
where the disease is endemic the usefulness of serological
methods is limited to epidemiological studies because
there are infected dogs that do not show a specific
antibody reaction.
An alternative approach to parasitological methods is
identification by using molecular biological techniques
such as specific PCR. Several Leishmania DNA targets
have been identified, and their values for use in a
PCR-based diagnosis were evaluated. The results of PCR
and in vitro cultivation showed an excellent congruence.
The sensitivities of both PCR and cultivation were 100%
with bone marrow biopsies and with lymph node aspirates
from dogs. Detection of the parasites in whole blood
samples was possible but had a lower sensitivity of
84%. This noninvasive blood PCR assay may be used as
an initial test, reducing the need for bone marrow biopsies
and especially to follow the parasitemia during treatment.
Sample:
1. Lymph node aspirate in sterile container.
2. Whole blood (3 ml) in a lavender top (EDTA) tube.
3. Tissue samples.
Special Handling:
Store blood sample at 4°C until pick
up or shipment.
Test Code:
D323
1. Roura et
al. (1999) Diagnosis of canine leishmaniasis by a polymerase
chain reaction technique. Vet. Rec. 144:262-264.
2. Ciaramella et al. (1997) A retrospective clinical study
of canine leishmaniasis in 150 dogs naturally infected
by Leishmania infantum. Vet. Rec. 141: 539-543.
Back to small animal DNA testing
|
 
|